An expert committee has advised against the adoption of malaria vaccines in India, stating the country does not meet the ...

India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...

India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...

Bharat Biotech International Limited (BBIL) on Tuesday announced the launch of HILLCHOL (BBV131), a novel single-strain Oral Cholera Vaccine (OCV). According to the company’s statement, HILLCHOL ...

Bharat Biotech has opted for this vaccine candidate owing to its advanced stage of clinical development as well as the extremely promising results from Phase 1 and Phase 2 clinical trials,” said ...

Novavax's R21/Matrix-M malaria vaccine, with 75% efficacy in seasonal areas. Affordable at $3 per dose, it outshines GSK's vaccine. Global rollout expected mid-2024.